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The  precise  cellular and  molecular mechanisms by  which  H-2-1inked  Ir  genes 
regulate immune responses  are still  poorly understood. We have recently reviewed 
this topic (1), and suggested  three general types of Ir control: (a) restrictions  on the 
production and/or effector function of antigen-specific  I-region coded T-cell derived 
helper or suppressor  factors;  (b) restrictions on the ability of Ia antigens, together with 
the nominal antigen, to trigger T cells, a phenomenon seen as H-2 haplotype restricted 
macrophage (Mq~)l-T-cell interaction or T helper cell (Tn)-B-cell cooperation; and (c) 
restrictions  on  the  T-cell  receptor  repertoire  presumably  induced  during  thymic 
differentiation in the presence  of one or another set of Ia antigens. This laboratory 
has  studied  in  detail  the  Ir  gene regulated response  to  the synthetic polypeptide 
antigen  L-glutamic acidO°-L-alaninea°-L-tyrosine  1°  (GAT)  as  a  model  for exploring 
these issues (2-5). The work dealing with soluble factors has been described elsewhere 
(6-10). Of concern here is the question of M@T-cell interaction in antibody responses. 
Early studies by Kapp et  al.  (3)  revealed that  responder  (R)  or  (responder  X 
nonresponder)Fx ([R  ×  NR]F1) spleen  cells give primary IgG plaque-forming cell 
(PFC)  responses  in vitro to either soluble  GAT or to GAT bound to M~k  (3). No 
differences  in the ability of R  or NR GAT-M~ to induce primary anti-GAT PFC 
responses in culture could be detected under the experimental conditions employed, 
suggesting that Ir-gene control of GAT responses was not expressed predominantly at 
the M~ or M@T-cell level. Further studies demonstrated that R or (R ×  NR)Fx mice 
could  be  primed  in  vivo  with  GAT-Mq~ such  that  their  spleen  cells would  give 
secondary in vitro responses only to GAT-Mq~ sharing the I-A subregion with the M~ 
* Supported by grants AI-09920  and  AI-00152  from the National Institute of Allergy and  Infectious 
Diseases, and grant CA-09130 from the National Cancer Institute, Department of Health, Education, and 
Welfare. 
l Abbreviations used in this paper." B6, C57BL/6;  (B6D1)Fh  (C57BL/6 female  ×  DBA/I  male)Fl; B10, 
C57BL/10;  CY, cyclophosphamide;  D1,  DBA/1; FCS, fetal  calf serum;  GAT, random  copolymer of L- 
glutamic acidO°-L-alanine3°-L-tyrosinel°; GT, random copolymer of L-glutamic  acidS°-L-tyrosineS°;  HBSS, 
Hanks' balanced salt solution;  la  Na, Ia antigens from Ir nonresponder haplotype; Ia  R, Ia antigens from Ir 
responder  haplotype; Mq~, macrophage(s);  NR, nonresponder;  PFC, plaque-forming cell(s); R, responder; 
SRBC, sheep erythrocytes;  (T,G)-A--L,  poly-L-(Tyr, Glu)-poly-D,L-Ala-poly-t.-Lys; TH, helper T cell(s); T., 
suppressor  T cells(s). 
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used for priming, which  could be of R  or NR origin  (5,  11,  12).  This restriction  in 
secondary anti-GAT PFC responses was found to be dependent on the T-cell and not 
the B-cell component of the primed spleen, and was presumably a  reflection of H-2 
restricted  TH activity.  Similar I-A restrictions of responsiveness in  mice primed for 
delayed type hypersensitivity (13)  or helper activity (14)  by antigen-pulsed Mth have 
been  reported  subsequently  by  several  groups.  More  recently,  it  was  found  that 
priming (R  ×  NR)F1 mice with soluble GAT, rather than M~bound GAT, resulted 
in spleen cells which gave secondary responses in vitro only to GAT-R-M~ and not to 
GAT-NR-MO (15).  This restriction, which correlates with Ir-gene status in the MO, 
and  not  lymphocyte population,  indicates  in  contrast  to  the  earlier  data,  Ir-gene 
expression at the level of M~  or M@T-cell interaction. 
Perhaps  the  most  striking  feature  of both  these  latter  studies  on  soluble  GAT- 
primed F1 mice (15)  and the former experiments on GAT-M@primed R  mice (5)  is 
the loss of the usual primary PFC response in (R  ×  NR)F1 mice to GAT-NR-Mth or 
in responder mice to GAT-Mq~ with H-2 haplotypes other than that used for priming. 
This loss of primary responsiveness, particularly to GAT-NR-MO, taken together with 
the known ability of soluble GAT to induce strong suppressor T  cell (Ts) responses in 
NR animals (16), suggested to us that in addition to the priming of H-2 restricted TH, 
the development of GAT-specific Ts might I~e important in determining the pattern 
of secondary responses to M@associated GAT. The present series of experiments tests 
this hypothesis, and demonstrates (a) the suppressive activity of primed (R  ×  NR)F1 
spleen  cells  on  primary  responses  to  GAT-NR-Mff  and  (b)  the  ability  of agents 
(cyclophosphamide  (CY)  (17)  and  antiserum  to  I-J  subregion  determinants  [18]) 
known to decrease T, activity, to permit primed F1 spleen cells to respond to GAT- 
NR-Mth, concomitant with the loss of suppressor activity in such primed spleen cell 
populations. Models of T-cell function in primed mice consistent with both the earlier 
I-A restriction  data  and  the current  experiments detailing  a  role for T,  in  M~TH 
restriction phenomena are discussed below. 
Materials and Methods 
Mice.  C57BL/6  (B6) or C57BL/10  (B10) H-2  b, DBA/1  (D1), H-2  q, and CBA,  H-2  k mice 
were purchased from the Jackson Laboratory, Bar Harbor, Maine. (C57BL/6 female ×  DBA/1 
male)F1 [(B6D1)F1] and (CBA female ×  DBA/1 male)F1 mice were bred in the Department of 
Pathology animal  facility.  B10.G,  H-2  q mice were the gift  of Dr. Martin  E.  Dorf,  Harvard 
Medical School.  All animals were maintained on standard laboratory chow and chlorinated 
water ad lib, and used at 8-20 wk old.  Mice used in any given experiment were age and sex 
matched as closely as possible. DBA/1 and B10.G mice are GAT nonresponders. B6, BI0, and 
CBA mice are responders. 
Antigens.  GAT lot 6 (Miles Laboratories Inc., Miles Research Products, Elkhart, Ind.) mol 
wt -- 38,000, was prepared for use as antigen in culture, for in vivo priming, and for preparation 
of GAT-sheep erythrocytes (GAT-SRBC) and GAT-Mth as previously described (2, 3). 
Immunization.  FI mice were primed by a single i.p. inoculation of 100 #g GAT in a mixture 
of aluminum-magnesium hydroxide gel (Maaiox, William H. Rorer, Inc., Ft. Washingon, Pa.) 
and pertussis vaccine (Eli Lilly and Co., Indianapolis, Ind.) administered 4-8 wk before removal 
of spleens  for culture. Some mice were pretreated 3 days before immunization with 5 mg/kg 
cyclophosphamide (Cytoxan, Mead Johnson Pharmaceutical Division,  Mead Johnson & Co., 
Evansville, Ind.) dissolved in saline. Other groups of mice were given four daily i.v. inoculations 
containing 5 #1 of an anti-I-J  b or anti-I-J  k antiserum diluted in saline, beginning on the day of 
immunization  (18). These antisera,  provided by Dr.  Martin  Dorf of this department, were 
raised and characterized as described previously (19). Anti-I-J  b =  B10.A(5R)  anti-B10.A(3R); 
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Preparation of GA T-M(o.  Macrophages were pulsed with GAT by either of two techniques. 
In  most  experiments,  GAT-bearing  M~  were  prepared  in  vitro  by  previously  described 
techniques (13). In brief, 2 ×  10e/ml of viable peptone induced peritoneal exudate cells (PEC) 
(>75% Mch) were incubated at 4°C for 1 h in 100 #g/ml GAT at pH 9-9.5, then washed four 
times in cold Hanks' balanced salt solution (HBSS) and resuspended in HBSS to the desired 
concentration  for addition  to  culture.  In  one  series  of experiments,  mice  injected  3  days 
previously with  1.5  ml of 10% protease peptone  (Difco  Laboratories, Detroit,  Mich.)  were 
inoculated i.p. with 100 #g of GAT in HBSS at neutral pH. 1 h later the peritoneal cavity was 
lavaged with  cold HBSS,  and  the  recovered cells  (60-90%  Mq~) washed  four times before 
resuspending in HBSS for addition to cultures (in vivo pulsed Mq0. 
Cell Culture and Hemolytic Plaque Assay.  All  cell  cultures  were performed according to a 
modified Mishell-Dutton protocol described  previously (19). 7.5  ×  10  e viable spleen  cells in 
completely supplemented Eagle's minimal essential  medium containing  10% fetal calf serum 
(FCS)  (Reheis  Chemical Division  of Armour Pharmaceutical Co., Chicago, Ill.) and  10 mM 
Hepes were cultured with soluble GAT (1-2.5 #g/ml) or GAT-M~ (104-4 ×  104) in a 1-ml final 
volume in the 16-mm wells of a flat-bottom tissue culture plate (FB-16-24TC, Linbro Chemical 
Co.,  Hamden, Conn.). These cultures were incubated with rocking for 5 days at 37°C in a 
humidified atmosphere of 10% CO2, 7% 02, 83% Na, and fed daily with 70 #1 of a  1:1 mixture 
of nutritional cocktail and FCS. At the end of this culture period, replicate wells were pooled, 
the cells washed three times, and GAT-specific IgG PFC determined by a slide modification of 
the Jerne hemolytic plaque assay, using GAT-SRBC as indicator cells. For the experiments 
involving mixtures of various spleen populations, 3.75 ×  l06 of each cell type were added in 0.5 
ml to each culture well, which were then stimulated and assayed as above. All data are from 
representative experiments, and are expressed as GAT-specific IgG PFC/culture of 7.5  ×  108 
spleen cells. 
Results 
Comparison of In  Vitro Stimulatory Activity  of Macrophages Pulsed with GA T In  Vivo or In 
Vitro.  Several studies have shown that nonresponder M~bearing GAT stimulate in 
vitro primary PFC responses by R  or (R  ×  NR)F1 spleen cells (3, 4,  15). These data 
differ from those obtained in studies  on secondary GAT responses of (R  ×  NR)Ft 
spleen cells (15) and experiments by others in both the mouse and guinea pig showing 
the  inability  of NR-derived  antigen-bearing  Mq~  to  trigger  T-cell  responses  to  Ir- 
controlled antigens (20-23). One possible explanation for these conflicting data is that 
NR-Mch pulsed with GAT under nonphysiologic conditions in vitro might artifactually 
be able to stimulate primary GAT responses, in comparison to NR-M~ bearing GAT 
acquired in vivo under more physiologic conditions (24).  To investigate this point, R 
(B6)  and NR(D1)  M~ were prepared either by the standard  in vitro method or by 
injecting  GAT i.p.  into  peptone pretreated  mice, followed by harvest  of the  GAT 
bearing PEC.  These in  vitro- and  in  vivo-pulsed Mq~ were then used  in culture  for 
stimulating  primary or secondary anti-GAT  PFC  responses using  (B6D1)F1  spleen 
cells. Table I presents data which reveal that in vivo prepared cells act identically to 
in vitro pulsed cells in terms of primary stimulation or pattern of secondary response 
restrictions.  Therefore, the mode of GAT-M~ preparation is not responsible, per se, 
for the pattern of activity of GAT-bcaring NR-Mth in triggering GAT PFC responses 
in vitro. 
GA T-Primed (R  ×  NR)Fa Spleen Cells Suppress the Prima~y Anti-GAT PFC Response to 
GAT-NR-MqJ.  To  test  the  hypothesis  that  the  absence  of  secondary  anti-GAT 
responses  to  GAT-NR-Mq~ was  at  least  in  part  attributable  to  active suppression, 
GAT-primed (R  ×  NR)Fa spleen cells exhibiting this restricted response pattern were 
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TABLE  I 
In Vitro Stimulato~y Activity  of in Vivo vs. in Vitro Pulsed GA T-Mep  for Primary and 
Secondary PFC Responses 
1327 
Responding (B6D1)FI  Antigen*  IgG GAT-specific 
spleen cells  PFC/culture 
Normal  1 #g GAT  300 
GAT-B6-M~ (In vitro)  395 
GAT-B6-Mck (In vivo)  728 
GAT-D1-Mck (In vitro)  550 
GAT-D1-M~k (In vivo)  728 
GAT-primed~:  1 #g GAT  390 
GAT-B6-Mq (In vitro)  345 
GAT-B6-Md? (In vivo)  660 
GAT-D l-M# (In vitro)  < 10 
GAT-D1-M# (In vivo)  <10 
* 2 ×  104 GAT-Mc  k prepared by pulsing with soluble GAT as described  in Materials 
and Methods, were added per culture. 
Animals primed i.p. with 100 #g GAT in Maalox-pertussis  5 wk before use. 
soluble GAT, GAT-B6 (R)-M~, or GAT-D1  (NR)-Mth.  If the failure of primed F1 
spleen cells to respond to GAT-D 1-M~ was due solely to the absence of a GAT-D 1- 
specific cell population, one would predict that the response in the mixture would be 
--~½ that of 7.5  ×  108 normal spleen cells alone.  If suppression  were involved in the 
secondary restrictions, however, the response of the cocultured cells to GAT-D 1-Mt~ 
should be ,aK½ that of the normal cells only. Table II shows that the response of such 
1:1 mixtures of normal and GAT-primed syngeneic F] spleen ceils to GAT-D 1-Mth is 
essentially at background levels (<15 PFC/cuhure); i.e., substantially less than one- 
half the 1977 PFC/culture of normal spleen cells alone stimulated by the same GAT- 
NR-Mth. This finding indicates the presence  of suppressor  cells in the primed spleen 
cell population, active on the PFC response to GAT-NR-Mq~. In contrast, stimulation 
with GAT-B6-Mth of either normal spleen  cells, GAT-primed spleen  cells, or a  1:1 
mixture of the two cell types gave virtually identical anti-GAT PFC (1,267 vs.  1,200 
vs.  1,095 PFC/culture, respectively).  This demonstrates that the suppressive  activity 
shown  by stimulating cocultures of normal  and  primed  cells  with  GAT-NR-Mth 
cannot be detected with GAT-R-Mq),  as expected from the responses of the primed 
cells  alone  to  such  GAT-R-M~.  As  discussed  below,  however,  these  data  do  not 
exclude the possibility that the primary response of the normal cells to GAT-B6-Mth 
was  also  suppressed,  but  that  this suppression  was  masked by the response  of the 
primed cells themselves to these GAT-R-Mff. Finally, identical 1:1 mixtures of  normal 
and  primed  cells  exposed  to soluble GAT, which would be  presented  by  F1  M~ 
possessing H-2  b (R) genes, give a significant PFC response, as expected. 
Ability of CY or Anti-I-J Antiserum Treatment to Permit Secondary Responses of Primed F1 
Spleen Cells to  GA T-NR-Md?.  As a  first  approach to determining the nature of the 
suppressive  activity in primed spleen  cells, two in vivo treatments known to reduce 
GAT-specific  suppressor  T-cell  activity  were  employed,  in  an  effort  to  prevent 
restriction of secondary GAT responses. Several groups of mice were pretreated with 
5 mg/kg freshly prepared CY i.p.,  3 days before  GAT priming. This protocol has 
been shown to prevent T, generation to polypeptide antigens in suppressor,  nonre- 1328  SUPPRESSOR 
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FIO.  1.  (B6DI)F1 mice were divided into three groups: (a) untreated; (b) primed with 100 #g GAT 
in adjuvant; or (c) pretreated with 5 mg/kg CY i.p., then primed with  100 #g GAT in adjuvant 3 
days later.  4  wk later, the spleen cells of mice from each group were used as responding cells in 
modified Mishell-Dutton cultures stimulated with either I gg GAT, or  104 GAT-pulsed B6-Mq~, or 
GAT-pulsed DI-M~. These cultures were assayed on day 5 for GAT-specifie IgG PFC using GAT- 
SRBC as indicator cells. Results are expressed as specific PFC/(7.5  ×  10  s cell) culture. 
sponder  mouse strains  (17) (R.  N.  Germain  et  al.,  unpublished  observations).  As 
shown in Fig. 1, such pretreatment permits GAT-primed spleen cells to give secondary 
responses not only to GAT-B6-M¢, as in the untreated group, but also to GAT-D1- 
M~. Similar data is presented in Tables II, IV, and V. In addition, Table II shows 
that mixtures of normal spleen cells together with spleen cells from CY-pretreated 
GAT primed mice do not show the suppression of responses to GAT-D I-Mq, found in 
similar cocuhures of normal plus untreated primed cells. 
In a  second type of experiment, mice were given 5 ~1 per day for 4  days of an 
antiserum directed against either the I-J  b subregion possessed by the F1, or against the 
I-J  k subregion as a control. This anti-I-J  k antiserum is from the same pool previously 
shown to prevent n-glutamic acidS°-n-tyrosine  5° (GT)-T8 activity in GT-primed CBA 
(H-2  k) mice (18). Such anti-I-J antiserum-treated mice were primed with GAT on the 
same day as the first anti-I-J antiserum injection and their spleen cells tested in vitro 
several weeks later. The data in Table III document that appropriate treatment with 
anti-I-J  b antiserum and not the control anti-I-J  k antiserum permits primed F1 mice to 
give secondary responses to GAT-D 1-Mq,. Thus, two different experimental regimens, 
known to interfere with antigen specific T8 function, have similar abilities to prevent 
the appearance of the restricted secondary response typical of untreated GAT-primed 
F1 mice. This provides further support  for the basic hypothesis that such restricted 
responses are in part a consequence of suppressor cell generation. 
Finally, the data in Table III (and in part, Table V) also indicate that the ability 
to trigger secondary anti-GAT PFC responses in primed (R ×  NR)F1 mice possessing 
suppressor cells is an H-2 linked phenomena. In this experiment, congenic mice B10 
(H-2b,R) or B 10.G (H-2 q, NR) were used as M~ sources. The results clearly show that 
GAT-B 10.G  (NR)-M~ behave identically to GAT-D1 (NR)-M~ and differently from 
GAT-B10 (R)-Mq, which differ only at the H-2 region. These data are (a) consistent 
with earlier studies mapping secondary GAT response restrictions to the I-A subregion 
of H-2  (11) and(b)  in  accord  with  the  notion  that  H-2-1inked  Ir-gene  status  is 
important in the suppressor related phenomenon being studied here. RONALD N. GERMAIN AND BARUJ BENACERRAF  1329 
TABLE II 
Suppression of GA T-D 1-Mep Induced Primary GA T-PFC Responses by GA T-Primed (B6D 1  )F1 
Spleen Cells 
Responding (B6DI)FI* spleen cells  Antigen:~  IgG GAT-specific 
PFC/cuhure 
Normal  1 #g GAT  1,027 
GAT-primed§  1 #g GAT  945 
CY-pretreated, GAT-primed§  1 #g GAT  645 
Normal + GAT-primed  1 btg GAT  353 
Normal +  CY-pretreated, GAT-primed  1 #g GAT  713 
Normal  GAT-B6-Mq~  1,267 
GAT-primed  GAT-B6-Mq~  1,200 
CY-pretreated, GAT-primed  GAT-B6-Mcb  1,223 
Normal +  GAT-primed  GAT-B6-M~  1,095 
Normal + CY-pretreated, GAT-primed  GAT-B6-M~  1,058 
Normal  GAT-D  1-M~  1,977 
GAT-primed  GAT-D  l-Mq~  < 15 
CY-pretreated, GAT-primed  GAT-D  1-M~  1,118 
Normal +  GAT-primed  GAT-DI-M~  <15 
Normal + CY-pretreated GAT-primed  GAT-D1-Mq~  1,043 
* 7.5 ×  106 spleen cells/culture. Mixtures contain 3.75 ×  l0  s spleen cells of each type. 
:~ 2 ×  104 in vitro prepared GAT-M~/culture. 
§ Mice primed with or without CY pretreatment as described in Materials and Methods. 
GA T-D I-Mdp Do Not Trigger a Nonspecific Suppression Able to Prevent Secondary Responses 
to  GAT-B6-Mep.  One  possible  interpretation  of the  data  presented  above  is  that 
during  antigen  priming,  suppressor cells specific for GAT in  association with  H-2  q 
antigens are preferentially induced and that such suppressor cells only function when 
GAT is  represented  on  a  D1  (H-2  q)  M~ surface.  Although  the  results  in  Table II 
showing responses of primed F1 spleen cells to soluble GAT (presumably presented by 
F1  MS with both H-2  b and H-2  q antigens)  appear to contradict  this hypothesis, an 
experiment  with  mixtures  of antigen-pulsed  Mq~ was undertaken  to  test  this  point 
more directly.  As can be seen in Table IV, the addition  of GAT-D1-M~ to primed 
cells together with GAT-B6-Mq~, failed to cause suppression of the usual  GAT-B6- 
M&induced response. The remainder of the table demonstrates that all the cells used 
in this experiment had the response patterns expected of them from the data given 
above. Thus, GAT-D1-M$ do not trigger an  (H-2  q plus antigen)  specific suppressor 
population to cause nonspecific suppression of GAT responses. This implies that the 
secondary  response to  GAT-B6-M~ is  not  simply a  result  of the  failure  to  trigger 
suppressor activity, but reflects, at a  minimum, a certain H-2 regulated resistance to 
the influence of the suppressor cells clearly existing in primed FI spleen cell popula- 
tions. 
Demonstration  of Suppressor-Mediated  Restrictions  of Secondary GAT PFC Responses  in 
Another  (R  ×  NR)F1 Strain.  To test whether the results obtained in the preceding 
experiments were of a  general  nature,  or peculiar to the  (B6D1)F1  only, a  limited 
number  of experiments  were  performed using  (CBA  X  D1)FI  mice.  As  shown  in 
Table  V,  priming  such  Fa  mice  with  GAT  yields  spleen  cells  giving  secondary 
responses in vitro only to R  (CBA) and not NR (D1 or B10.G) GAT-Mq~. Further, the TABLE III 
Treatment with Anti-I-J b Antiserum at the Time of GA T Priming Prevents the Suppression 
Detected in Secondary in  Vitro Responses of (B6D1)Fx to GA T-D I-Mc~ 
Responding (B6D1)FI*  spleen cells  Antigen:~  IgG GAT-specific 
PFC/culture 
Exp. I 
Normal 
GAT-primed 
Anti-I-J  k treated, GAT-primed 
Anti-I-J  b treated, GAT-primed 
1 #g GAT  405 
GAT-D1-Mq~  235 
1 #g GAT  435 
GAT-D t-Mq~  < 10 
1 #g GAT  490 
GAT- D 1-Mq~  < 10 
1 p,g GAT  260 
GAT-D 1-Mq~  35O 
Exp. II 
Normal 
Anti-I-J  k treated, GAT-primed 
Anti-I-J  b treated, GAT-primed 
1 #g GAT  240 
GAT-B 10-M~k  460 
GAT-B 10.G-M~k  290 
GAT-D 1-M~#  315 
1 #g GAT  710 
GAT-B 10-Mq~  905 
GAT-B 10.G-M~  10 
GAT-D1-Mq~  <10 
1 #g GAT  240 
GAT-B 10-Mqb  260 
GAT-B 10.G-Mq~  265 
GAT-D1-Mq~  255 
* Mice primed with GAT and treated with anti-I-J  k [B 10.A(3R) anti-B 10.A(5R)] or 
[B 10.A(5R)  anti-B 10.A(3R)]  as described in Materials and Methods. 
:~ 1 ×  104 in vitro prepared GAT-Mqb per culture. 
anti-I-J  b 
TABLE IV 
GA T-DBA/ l-Macrophages Do Not Inhibit the Response of GA T-Primed (Responder[B6] × 
Nonresponder [D I])F1 Spleen Cells to GA T-B6-Macrophages 
Responding (B6D1)F1 spleen  Antigen*  IgG GAT-specific 
cells  PFC/culture 
Normal  1 #g GAT  275 
GAT-B6-Mq~  265 
GAT-D1-Mq~  186 
GAT-B6-Mck  +  GAT-D1-MO  225 
GAT-primed~  1 #g GAT  1,250 
GAT-B6-Mqb  855 
GAT-D 1  -M~  < 10 
GAT-B6-Mq~ +  GAT-D1-Mq~  1,115 
CY-pretreated,§ GAT-primed  1 #g GAT  570 
GAT-B6-Mck  645 
GAT-D 1-Mq~  520 
GAT-B6-M¢, +  GAT-DI-Mq~  710 
* GAT-Mqb prepared in vitro as described in Materials and Methods.  2  ×  104 GAT-M~k of the 
indicated type were added to each culture. 
:~ Animals were primed i.p. with 100 #g GAT in Maalox-pertussis 5 wk before use. 
§ Mice were pretreated with 5 mg/kg CY i.p. 3 days before GAT priming. 
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TABLE  V 
Effect of Cyclophosphamide on Male-Restricted Secondary in Vitro Responses of (Responder 
[CBA] × Nonresponder  [DI])F, Mice 
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Responding (CBA  X D1)F1*  Antigen:[:  IgG GAT-specific 
spleen cells  PFC/culture 
Exp. I 
Normal 
GAT-primed 
Exp. II 
Normal 
GAT-primed 
CY-pretreated,  GAT-primed 
1 #g GAT  310 
GAT-CBA-Mq~  625 
GAT-D 1-Mth  520 
1 p,g GAT  520 
GAT-GBA-MqJ  555 
GAT-D 1-Mq~  115 
GAT-CBA-Mq~  505 
GAT-D l-Mq~  495 
GAT-B  10.G-M~  760 
GAT-CBA-Mq~  l, 130 
GAT-D  1  -Mq~  40 
GAT-B 10.G-M¢  290 
GAT-CBA-Mq~  615 
GAT-D1-M#  635 
GAT-B 10.G-Mq~  530 
* Mice primed with or without CY pretreatment  as described  in Materials  and Methods. 
:[: 1 ×  104 GAT-M~ prepared  in vitro per culture. 
restricted response pattern of such primed mice is prevented, as before, by pretreat- 
ment with CY. Suppressive activity of primed (CBA  X  D1)F1 spleen cells mixed 1:1 
with normal F1 cells for responses to GAT-D1-M¢ was also found (data not shown). 
Therefore,  the  basic  observation  of a  role  for  suppressor  cells  in  H-2  restricted 
secondary PFC responses in vitro appears to be a general phenomenon in the GAT 
model. 
Discussion 
The  experiments  described  above  support  the  conclusion  that  for  the  Ir-gene- 
regulated antigen GAT, the lack of secondary PFC responses by GAT-primed (R  × 
NK)Fx  to antigen  presented  on  NR  Me  is in  large  measure a  reflection  of active 
suppression selectively limiting lymphocyte stimulation by GAT-NR-Mq~ in compar- 
ison to GAT-R-M~.  In addition, the data strongly suggest that the suppressor cells 
active in this model arc T  cells.  The evidence for these conclusions derives from (a) 
the  direct  demonstration of the suppressive activity  of GAT-primed  (R  ×  NR)F1 
spleen  cells  on primary  PFC  responses of normal  Fa spleen  cells  to  GAT-NR-M~ 
(Table  II)  and  (b)  the  ability  of CY or anti-I-J  s  antiserum  treatments  (known  to 
remove GAT-specific suppressor T-cell activity in vivo) to prevent GAT priming from 
leading to restricted  secondary responses to GAT-NR-M¢ (Tables II-V and Fig.  1). 
Furthermore, susceptibility to restriction of secondary responses by suppressor cells is 
controlled by the H-2 complex, as shown by the difference in secondary responsiveness 
of (BfD1)F1  spleen cells  to GAT-Mq~ from the H-2 congenic pair B10  (H-2  b)  and 
B10.G  (H-2  q)  (Table  IV).  The  data  are  consistent  with  similar  results  recently 
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The major unresolved issue raised by these experiments is the relationship between 
the generation of suppressor cells and the selective loss of responsiveness to GAT-NR- 
M~ in GAT primed  (R  x  NR)Fa mice. Several features of GAT as an antigen are 
relevant to this question. First, mice of nonresponder H-2 haplotype will give primary 
in vivo GAT PFC responses after maneuvers to reduce Ts activity, i.e.  CY pretreat- 
ment, anti-I-J antiserum treatment, or adult thymectomy. This implies that such NR 
mice  are  capable  of some  detectable  GAT  specific  M~  antigen  presentation  and, 
albeit  weak,  TH  function,  if  the  obscuring  action  of  T.  is  first  removed.  This 
interpretation is strengthened by previous direct demonstrations that NR Mq~-bearing 
GAT can prime R  and NR mice for radioresistant  (NR-M~ restricted)  TH function 
(4).  Second, GAT readily induces specific T~ in NR mice in vivo (16) or in vitro (19), 
and can activate similar T~ in vitro in responder spleen cell populations depleted of 
M~p by adherence methods.  2 These various observations taken together indicate that 
NR  M4~  are  not  absolutely  deficient  in  their  ability  to  present  GAT  to  mouse 
lymphocytes of R  or NR origin, thus explaining the primary in vitro response of (R 
X  NR)Fx to GAT-D1-M~. Furthermore, the relative absence of appropriate Mq~ GAT 
presentation seems to favor predominance of T~ over TH. Finally, the detection of TH 
responses elicited by NR M~ requires either pretreatment to reduce T~ activity or the 
presentation of GAT solely on appropriately pulsed Mq~, which apparently achieves 
the same end. 
These conclusions provide a framework for the analysis of the Ir related restrictions 
in secondary responses of GAT primed (R  ×  NR)Fx mice. We propose that injection 
of soluble GAT into such F1 mice triggers at least three populations of T  lymphocytes: 
one set of Tn specific for GAT presented in the context of responder Ia (IaR), one set 
of Tn triggered in the absence of IaR-GAT presentation, and a minimum of one set of 
GAT specific T.. From previous data showing that even in the absence of T~ activity, 
NR mice make a  much smaller GAT PFC response than R  to the same stimulus,  it 
can be postulated that the TH set specific for GAT-Ia  R is much larger or more active 
than the TH set not associated with Ia  R. The Ts response to the GAT used for priming 
is likely to be sufficient to overwhelm this weaker Tn response but  not the stronger 
GAT-IaR-associated TH response. Thus, only GAT-R-Mq~ responsive primed TH will 
exist in sufficient number to trigger secondary responses in the face of the T~ present 
in the splenic population. It should be noted that this hypothesis makes no distinction 
between T~ arising as a result of direct antigen activation of T~ precursors, or those T~ 
stimulated through feedback induction of Lyt 1,2,3+Qal + cells by Lyt 1  + cells (26,  27). 
Furthermore, it is probable that what we discussed above in purely quantitative terms 
may also be a  reflection of a  qualitative change in activated TH, which reduces their 
susceptibility to suppression, a This theory also relies on the notion that suppression is 
a  normal  accompaniment of antigen  priming  (28-30),  and  that  there  is  a  distinct 
difference in the efficiency with which GAT triggers TH precursors when associated 
with Ia  R vs. Ia  NR. Attempts to reassess R  vs. NR Mq~ presentation of GAT under more 
2 M.  Pierres and  R.  N. Germain.  1978, Antigen-specific T-cell mediated suppression. IV.  Role of 
macrophages in generation of L-glutamic acide'°-L-alaninea°-a~-tyrosine  ~° (GAT)-specific  suppressor T-cells 
in responder mouse strains.J.  Immunol. In press. 
a In this regard, the T~ present in the GAT primed FI spleen cells are probably able to suppress primary 
responses to GAT-B6-M~  as well. This could be examined by evaluating the responses of normal spleen 
cells to GAT-B6-Mq~ in the presence of purified Lyt2,3  ÷ Ts from primed F1 mice. Such experiments are 
currently in progress, as are studies on the M~ restriction of radioresistant memory Tn from untreated or 
CY pretreated GAT primed (R ×  NR)FI mice. RONALD N. GERMAIN AND BARUJ BENACERRAF  1333 
limiting (Mtk or T  cell) conditions than formerly employed are in progress to establish 
the validity of this latter assumption. 
A  second  hypothesis to explain  the  current  results  would  postulate  that  T, are 
specific for (H-2 +  GAT), and that such H-2 restricted Ts are preferentially stimulated 
by H-2  NR vs. H-2  R. As indicated above, this hypothesis is made unlikely by the ability 
of mixtures of GAT-B6-Mth and GAT-D1-Mff, or soluble GAT, to give substantial 
GAT responses with primed (B6D1)F1 spleen cells, because (H-2  q +  GAT)-restricted 
Ts should be triggered under these circumstances to act on the Fx TH bearing both H- 
2  b and H-2  q. Allelic exclusion of the relevant H-2 region on the Tn would explain this 
result, but no evidence in favor of this possibility yet exists. Furthermore, Pierce et al. 
(5) have shown that GAT-Mg~ primed mice cannot give secondary responses to GAT- 
Mq~  of H-2  haplotypes  not  present  during  the  priming,  a  finding  which  is  also 
inconsistent with  this interpretation.  Similarly, a  third explanation postulating the 
occurrence of T, after priming which would recognize the idiotype of the antigen 
receptors of TH specific for GAT-Ia  NR is compatible with the requirement for allelic 
exclusion just discussed, but would not explain the third party nonresponse (suppres- 
sion)  seen  by  Pierce et  al.  Therefore, the  first  hypothesis appears  to  be  the  most 
attractive working model. 
Several other investigators have studied secondary responses to Ir-controlled anti- 
gens  presented  by  R  or NR  Mth.  In  both  guinea  pig and  murine  systems,  (R  × 
NR)Fl-primed T-cell proliferation to such antigens occurs only when these molecules 
are presented on M~bearing responder Ia antigens  (20,  21, 24).  Recent studies by 
Yano et  al.  (31)  have utilized a  similar approach to that  employed in  the present 
study to evaluate the role of T~ in limiting secondary proliferative responses to GAT- 
NR-M~.  Neither pretreatment with CY or adult thymectomy before immunization, 
nor removal of Lyt2  + T~ at the time of assay revealed a latent response to GAT-NR- 
Mth. The reason for this difference between proliferative and PFC assays for assessment 
of  GAT-NR-Mq~  function  is  unclear  at  present.  It  may  be  a  reflection  of the 
involvement of distinct T-cell subsets in the two types of responses, or an indication 
that  TH function may proceed without  a  cell division step  that  requires GAT-Ia  R 
triggering.  Alternatively, differences in assay sensitivity and other technical consid- 
erations may be the determining factors. It is clear that  further study is needed to 
resolve this issue. 
In a  primary in vitro model, Singer et al.  (22)  have demonstrated that for TNP- 
poly-L-(Tyr, Glu)-poly-D,L-Ala-poly-L-Lys [(T,G)-A--L], only R  and not NR Mt~ can 
trigger PFC responses, and have suggested that this reflects the inability of [Ia  NR  + 
(T,G)-A--L] to trigger (R  ×  NR)Fa lymphocytes. These data are quite distinct from 
those obtained using GAT, which regularly stimulates primary PFC responses when 
presented on NR-M~.  It is unlikely that  the results in the GAT model are solely a 
reflection of antigen transfer to R Mth since (1) in the secondary cultures, such transfer 
to the F1 Mq~ would lead to responses due to GAT-H-2  b antigen presentation, and 
such responses are not seen and (2) NR mice can be primed with and can respond to 
GAT under the appropriate circumstances in the absence of any R  Mq~ (see above). 
It is therefore more probable that  the difference between the (T,G)-A--L and GAT 
systems reflects a  more profound inability on the part of NR-Mth to trigger any Trt 
activity for (T,G)-A--L vs. GAT, i.e. that the GAT Ir gene, as expressed in the NR at 
the M~TH level, is leaky. Although the simplest explanation for this minimal helper 1334  SUPPRESSOR  T-CELL  REGULATION OF  SECONDARY  RESPONSES 
function in GAT-NR is that (Ia  NR +  GAT) can produce a weak immunogen capable 
of stimulating cells  from  the  same  Ia  restricted Tn  subset  as  GAT-Ia  1~,  it  is  also 
possible that help and suppression are intimately linked in the GAT system through 
the feedback loop described by Eardley et al. (26).  In this case, the NR TH activity 
might  in  fact  be  mediated  by  a  distinct class  of Lytl  +  I-J  + cells  responsible  for 
feedback suppressor  induction and also  helper function (2).  In either case, we no 
longer perceive any major difficulties in applying to the GAT model a general theory 
of Ir-gene  function  based  (a)  on  the  identity of some  Ir-gene  products  with  Ia 
molecules on macrophages and B cells and (b) on the importance of antigen presen- 
tation to T cells in the context of the macrophages' Ia molecules (1). The GAT system, 
however,  with  its  unequal  balance  between  TH  and  T8  induction  in  R  vs.  NR 
haplotypes, may reflect more accurately and informatively the complexities encoun- 
tered in studies of immune responses to native antigens capable of stimulating both 
T8 and TH responses concommitantly. 
The present study on the respective roles of haplotype restricted TH priming and of 
T~  activity  in  regulating  secondary  immune  responses  also  has  implications  for 
antigens not under unigenic Ir control. It is becoming clear that responses to distinct 
determinants of a  complex antigen molecule must be considered separately to fully 
understand  the  overall  response  to  that  antigen  (33-35).  Intramolecular  antigen 
competition may reveal itself as a low overall response to a given molecule, due to Ts 
which act preferentially on the TH to one vs. another epitope. This in turn may reflect 
an imbalance in (Ia  +  determinant  1) vs.  (Ia  +  determinant 2) immunogenicity in 
analogy to the difference postulated above for (Ia  R +  GAT) vs. (Ia  t~R +  GAT). Thus, 
what we generally view as an immune response may not reflect the balance of TH vs. 
T, triggered by an antigen as a  single entity, but rather the outcome of a  series  of 
distinct TH-T~ competitions whose overall balance reflects the sum of action at the 
M@T-ceU level of Ir genes specific for each determinant of the entire molecule. It is 
likely that  direct  demonstration  of such  Ir control  of epitope  specific TH and  T~ 
subsets  will  soon  be  available  from  studies  on  sequenced  polypeptides  and  their 
fragments. 
Summary 
(Responder [R]  X  nonresponder [NR])F1  mice give indistinguishable primary in 
vitro plaque-forming cell (PFC)  responses to either R  or NR parental macrophages 
(Mth)  pulsed  with  the  Ir-gene  controlled  antigen  L-glutamic  acidB°-L-alaninea°-L  - 
tyrosine  1° (GAT). However, such (R  X  NR)F1 mice, if primed to GAT, retained in 
vitro responsiveness to GAT-R-Mth, but no longer responded to GAT-NR-M~. This 
suggested (a)  a  possible M@related locus for Ir gene activity in this model, and (b) 
the occurrence of active suppression after priming with GAT leading to a  selective 
loss of the usual primary responsiveness of (R  X  NR)F1 mice to GAT-NR-Mff. This 
latter interpretation was tested in the current study. [Responder C57BL/6 (H-2  b)  X 
nonresponder  DBA/1  (H-2q)]F1  mice were  primed  with  100  #g GAT  in  pertussis 
adjuvant. 4-8 wk later, spleen cells from such mice were tested alone or mixed with 
normal unprimed F1 spleen cells for PFC responses to GAT-R-Mth and GAT-NR- 
Mff. The  primed  cells  failed to respond  to  GAT-NR-Mth,  and  moreover,  actively 
suppressed the normal response of unprimed F1 cells to GAT-NR-Mt  h. If the primed 
spleen cell donor had been treated with 5 mg/kg cyclophosphamide 3 days before RONALD N. GERMAIN AND BARUJ BENACERRAF  1335 
priming or with 5-10 #l/day of an antiserum to the I-J  b subregion [B10.A(5R)  anti 
B10.A(3R)]  during the first 4  days postpriming  (both procedures known to inhibit 
suppressor T-cell activity), cells from such mice responded in secondary culture to 
both GAT-R-Mth and  also GAT-NR-M4~.  In  addition,  such  spleen cells no longer 
were capable of suppressing normal Fx cells in response to GAT-NR-Mq. Similar data 
were obtained using [CBA (H-2  k)  ×  DBA/1  (H-2q)]F1. Further, it was shown that (a) 
primary responsiveness to GAT-NR-M~ was not an artifact of in vitro Mth pulsing, 
because in  vivo GAT-pulsed Mth showed the  same activity and  (b)  the secondary 
restriction for M~-antigen  presentation was controlled by H-2 linked  genes.  These 
data suggest an important role for suppressor T  cells in H-2 restricted secondary PFC 
responses, and also provide additional support for the hypothesis that  Ir-gene con- 
trolled differences in  M~k  antigen  presentation  are  related  to  both  suppressor  cell 
generation and overall responsiveness in the GAT model. 
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Diane Cannata for preparing this manuscript. 
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